Abstract:Introduction. The increasing prevalence and growing resistance of fungi present a significant peril to public health. There are only four classes of antifungal medicines available today, and few candidates are in clinical trials. Hypothesis/Gap Statement. Rapid and sensitive diagnostic techniques are lacking for most fungal pathogens, and those that do exist are expensive or hard to obtain. Aim. This study aimed to evaluate the feasibility of a novel automated antifungal susceptibility testing system, Fungus AST, in comparison to the broth microdilution method (BMD) recommended by the Clinical and Laboratory Standards Institute (CLSI). Methodology. A total of 101 clinical Candida spp. isolates were collected from the Zengcheng Branch of Nanfang Hospital and subjected to antifungal susceptibility testing. Antifungal susceptibility was assessed using the Fungus AST method and the BMD. Results. In this study, we introduce a novel automated antifungal susceptibility testing system, Fungus AST, which detects the turbidity and/or colour intensity of microdilution wells using a four-wavelength detection technology in real time and is designed to match the growth characteristics of strains over time. Based on our analysis, all reportable ranges of Fungus AST were suitable for clinical fungal isolates in PR China. Within ±twofold dilutions, reproducibility was 100 %. Considering the BMD as a referenced method, ten antifungal agents (anidulafungin, caspofungin, micafungin, fluconazole, voriconazole, posaconazole, itraconazole, amphotericin B, 5-flucytosine and nystatin) showed an essential agreement of >95 %. The category agreement of five antifungal agents (anidulafungin, caspofungin, micafungin, fluconazole and voriconazole) was excellent at >90 %. One Candida albicans isolate and voriconazole showed a major error (ME) (1.7 %), and no other ME or very ME agents were found. Conclusion. Given the above, it can be argued that the utilization of Fungus AST is a discretionary automated approach. More improvements are needed in Fungus AST compared to the BMD system for a wider range of clinical isolates, including different types of fungi.

Evaluation of three methods for testing yeasts susceptibility to fluconazole

Comparative Evaluation of ATB FUNGUS 3 Procedure and CLSI M27-A2 Broth Microdilution Method for Antifungal Susceptibility Testing of Pathogenic Yeasts

Comparison of four different methods in testing the in vitro susceptibility of Candida to fluconazole and voriconazole

Comparative evaluation of ATB FUNGUS 2 procedure and CLSI M27-A2 broth microdilution method for antifungal susceptibility testing of Candida species and Cryptococcus neoformans

The evaluation of rosco disk diffusion on fluconazole susceptibility test of yeast-like fungi

Antifungal Susceptibility Testing with Three Different Agars:A Comparative Study

Assaying the Susceptibility of Fluconazole-Resistant Candida Albicans to Common Antifungal Drugs

Antifungal Susceptibility Testing of 100 Clinical Isolates of Pathogenic Yeasts

Comparative Evaluation of Sensititre YeastOne and VITEK 2 Against the Clinical and Laboratory Standards Institute M27-E4 Reference Broth Microdilution Method for the Antifungal Susceptibility Testing of Cryptococcus Neoformans and Cryptococcus Gattii

Levofloxacin susceptibility testing for Helicobacter pylori in China: comparison of E-test and disk diffusion method.

Observing the Susceptibility of Candida Albicans Challenge with Fluconazole and Itraconazole by M27-A Microdilution Method

Drug Resistance Analysis of Clinical Fungus by Rosco K-B Method

Comparison of two approaches for observing susceptibility of antifungal agents to Candida species determined by microdilution method

Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method

Comparison of susceptibility testing by EUCAST and CLSI broth microdilution methods against Aspergillus isolates

The research of rapid susceptibility testing of candida species by flow cytometry

Antifungal Susceptibility Testing of Candida Albicans Isolated from Recurrent Vulvovaginal Candidiasis

Analysis of antifungal susceptibility in vitro and fungi distribution in clinics

In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.

Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?

Novel automated antifungal susceptibility testing system for yeasts based on dual-detection algorithm of turbidimetry and colorimetry